Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERYTHROPOIETIN: 7,963 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
7,963
Total FAERS Reports
1,199 (15.1%)
Deaths Reported
1,736
Hospitalizations
7,963
As Primary/Secondary Suspect
248
Life-Threatening
51
Disabilities

First Report: 19930212 · Latest Report: 20250825

What Are the Most Common ERYTHROPOIETIN Side Effects?

#1 Most Reported
Product storage error
1,286 reports (16.1%)
#2 Most Reported
Death
871 reports (10.9%)
#3 Most Reported
Circumstance or information capable of leading to medication error
592 reports (7.4%)

All ERYTHROPOIETIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Product storage error 1,286 16.2% 1 20
Death 871 10.9% 854 62
Circumstance or information capable of leading to medication error 592 7.4% 0 3
Off label use 590 7.4% 66 130
Haemoglobin decreased 443 5.6% 18 143
Drug ineffective 370 4.7% 31 74
Anaemia 367 4.6% 36 157
Intercepted product administration error 301 3.8% 0 2
Incorrect product storage 268 3.4% 0 9
Fatigue 266 3.3% 21 62
Drug dose omission 240 3.0% 4 20
Hospitalisation 229 2.9% 24 211
Aplasia pure red cell 204 2.6% 9 66
Asthenia 173 2.2% 28 65
Dyspnoea 173 2.2% 22 67
Diarrhoea 171 2.2% 23 48
Cerebrovascular accident 159 2.0% 36 119
Wrong technique in product usage process 156 2.0% 0 3
Haemoglobin abnormal 154 1.9% 2 30
Malaise 140 1.8% 15 57

Who Reports ERYTHROPOIETIN Side Effects? Age & Gender Data

Gender: 52.5% female, 47.5% male. Average age: 62.9 years. Most reports from: US. View detailed demographics →

Is ERYTHROPOIETIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2001 3 0 1
2002 11 4 4
2003 9 1 3
2004 9 1 5
2005 7 3 2
2006 12 1 4
2007 11 2 5
2008 21 1 17
2009 19 0 4
2010 95 2 17
2011 51 6 8
2012 33 6 14
2013 68 15 29
2014 238 65 60
2015 399 70 98
2016 404 88 95
2017 462 93 136
2018 399 75 130
2019 395 38 129
2020 301 32 72
2021 258 29 69
2022 237 27 32
2023 246 30 43
2024 204 9 41
2025 42 8 11

View full timeline →

What Is ERYTHROPOIETIN Used For?

IndicationReports
Product used for unknown indication 4,000
Anaemia 1,269
Nephrogenic anaemia 750
Chronic kidney disease 482
Myelodysplastic syndrome 215
Haemoglobin decreased 128
End stage renal disease 73
Anaemia of chronic disease 57
Off label use 43
Renal failure 36

ERYTHROPOIETIN vs Alternatives: Which Is Safer?

ERYTHROPOIETIN vs ESCHERICHIA COLI ERYTHROPOIETIN vs ESCITALOPRAM ERYTHROPOIETIN vs ESCITALOPRAM OXALATE ERYTHROPOIETIN vs ESKETAMINE ERYTHROPOIETIN vs ESLICARBAZEPINE ERYTHROPOIETIN vs ESMOLOL ERYTHROPOIETIN vs ESOMEPRAZOLE ERYTHROPOIETIN vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE ERYTHROPOIETIN vs ESOMEPRAZOLE\NAPROXEN ERYTHROPOIETIN vs ESTAZOLAM

Official FDA Label for ERYTHROPOIETIN

Official prescribing information from the FDA-approved drug label.